PSCH vs. PBE ETF Comparison

Comparison of PowerShares S&P SmallCap Health Care Portfolio (PSCH) to PowerShares Dynamic Biotech & Genome (PBE)
PSCH

PowerShares S&P SmallCap Health Care Portfolio

PSCH Description

The PowerShares S&P SmallCap Health Care Portfolio (Fund) is based on the S&P SmallCap 600® Capped Health Care Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to measure the overall performance of common stocks in the health care sector. Included are healthcare companies principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Index is a subset of the S&P SmallCap 600® Index, which is a float-adjusted, market-capitalization-weighted index reflecting the US small-cap market. The Fund and the Index are rebalanced and reconstituted quarterly.

Grade (RS Rating)

Last Trade

$44.99

Average Daily Volume

11,951

Number of Holdings *

69

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$66.59

Average Daily Volume

5,664

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
Period PSCH PBE
30 Days -0.40% -3.87%
60 Days -3.56% -6.68%
90 Days -2.03% -7.02%
12 Months 19.99% 17.18%
7 Overlapping Holdings
Symbol Grade Weight in PSCH Weight in PBE Overlap
COLL F 0.65% 2.27% 0.65%
CPRX C 1.67% 3.0% 1.67%
MYGN F 0.99% 1.61% 0.99%
PTGX D 1.7% 2.75% 1.7%
TGTX B 2.4% 3.78% 2.4%
VCEL A 1.65% 2.79% 1.65%
XNCR B 0.91% 3.88% 0.91%
PSCH Overweight 62 Positions Relative to PBE
Symbol Grade Weight
GKOS A 4.86%
MMSI A 3.73%
INSP F 3.66%
CORT C 3.46%
ADMA C 3.29%
KRYS C 3.15%
ALKS C 2.97%
RDNT B 2.95%
ITGR B 2.86%
HIMS C 2.77%
ICUI D 2.7%
OGN F 2.58%
SEM B 2.58%
PBH A 2.49%
CRVL A 2.04%
TMDX F 1.79%
NARI C 1.61%
UFPT C 1.57%
PINC B 1.5%
OMCL C 1.44%
ADUS D 1.43%
CNMD C 1.41%
LGND C 1.38%
PRVA C 1.36%
LMAT A 1.33%
FTRE D 1.31%
SUPN B 1.26%
NEO C 1.26%
TNDM F 1.25%
ASTH F 1.22%
AMPH F 1.15%
NHC B 1.04%
IART C 1.03%
PDCO F 1.02%
DVAX C 0.99%
STAA F 0.91%
USPH C 0.89%
HRMY F 0.86%
MD C 0.83%
PGNY F 0.81%
CERT F 0.75%
AMN F 0.69%
INVA C 0.69%
AORT B 0.68%
AHCO D 0.67%
SDGR C 0.65%
ANIP D 0.64%
OMI F 0.6%
RCUS F 0.6%
AVNS F 0.59%
BLFS C 0.59%
EMBC D 0.56%
VIR F 0.55%
PCRX C 0.5%
HSTM A 0.48%
CTKB C 0.47%
IRWD F 0.44%
MLAB F 0.4%
RGNX D 0.32%
SLP F 0.31%
PAHC B 0.3%
FLGT F 0.24%
PSCH Underweight 23 Positions Relative to PBE
Symbol Grade Weight
UTHR C -5.74%
ILMN C -5.64%
ALNY D -4.78%
AMGN D -4.7%
BIIB F -4.21%
NBIX C -4.18%
EXEL B -3.86%
BMRN F -3.76%
MNKD B -3.7%
NTRA A -3.56%
REGN F -3.38%
INCY C -3.35%
VCYT B -3.28%
ACAD C -3.06%
BPMC C -2.91%
TECH F -2.89%
OPK B -2.78%
RGEN F -2.76%
QGEN F -2.59%
BCRX D -2.56%
HALO F -2.42%
CDNA D -1.92%
NVAX F -1.83%
Compare ETFs